Connor Johnson

Jan 14, 2025 | biorxiv.org | Emily Martin |Connor Johnson |Allison M. Nalesnik |Ian S. Kovacs

AbstractInvasive sea lamprey (Petromyzon marinus) in the Laurentian Great Lakes have negatively impacted ecological and economically important fishes for nearly a century. To mitigate these negative effects, the lampricide 3-trifluoromethyl-4-nitrophenol (TFM) is applied annually to Great Lakes tributaries to kill larval lampreys before they become juveniles, out-migrate to the lakes, and parasitize other fishes.

Oct 18, 2024 | winol.co.uk | Connor Johnson

Landmarks up and down the country such as the Mayflower Theatre, Spinnaker Tower and, The Grand Pier were illuminated in purple on Sunday night in aid of Secondary Breast Cancer, with October being Breast Cancer Awareness month. This is the 2nd year of Make 2nds Count and their initiative to get the word out about Secondary Breast Cancer, with a 25% increase of landmarks involved in getting illuminated compared to last year.

Apr 10, 2024 | news.uark.edu | Connor Johnson

The Department of Theatre in the Fulbright College of Arts and Sciences presents the ArkTypes New Works Festival featuring readings of a number of new plays this weekend, April 12-14, at the Global Campus Theater on the Fayetteville square. All readings are free and open to the public. Reservations are recommended, and tickets can be reserved online, while also available at the door.

Nov 17, 2023 | ksuthorobrednews.org | Connor Johnson

FRANKFORT, Ky. — The Kentucky State University community was witness to a major power outage that hit the campus Thursday afternoon, when lights started flickering around lunchtime. Due to strong winds throughout Frankfort, all of Kentucky State’s campus was temporarily closed, including Young Hall, The Halls, and the construction site of the new dorm. The university released a statement via school email and its Instagram page, explaining the situation.

May 4, 2023 | oncologytube.com | P. Connor Johnson |Connor Johnson

Polatuzumab Vedotin: How can the POLARIX trial help us comprehend DLBCL? Connor Johnson MDBy P. Connor Johnson, MDMy name is Connor Johnson, and I am the medical oncologist at the Center for Lymphoma in the Massachusetts General Hospital Cancer Center. It is my privilege today to discuss the POLARIX trial, which potentially changes the standard of care for the treatment of diffuse large B-cell lymphoma, the most common lymphoma.